
MAZE vs REPL
$MAZE vs $REPL head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
MAZE vs REPL: the quick read
- ·MAZE is the larger company by market cap ($1.46B vs $1.24B).
- ·MAZE has been more active on our scanner (120 vs 100 alerts in 30 days).
- ·MAZE has the smaller float (52.8M vs 94.2M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Biological Products, (No Diagnostic Substances) vs BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 120 and 100 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 17% of each other on market cap, which makes the rest of this table the interesting part.
- ·They have diverged badly over the year: REPL is near the top of its 52-week range while MAZE is near the bottom of its own.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing MAZE and REPL on TheDesperateTrader.
- Is MAZE or REPL the better stock?
- "Better" depends on your goal, and these two are not alike. MAZE is the larger company by market cap ($1.46B vs $1.24B). MAZE has been more active on our scanner (120 vs 100 alerts in 30 days). MAZE has the smaller float (52.8M vs 94.2M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between MAZE and REPL?
- The differences that matter: they are not in the same business - MAZE is biological products, (no diagnostic substances) and REPL is biological products, (no diagnostic substances); they are similar in size ($1.46B vs $1.24B); they trade at very different share prices ($26.25 vs $13.20); MAZE sits at 14% of its 52-week range against 79% for REPL; our scanner flagged MAZE 120 times in the last 30 days against 100 for REPL. Everything above is measured from the latest completed session and SEC filings.
- Which of MAZE and REPL is more active right now?
- Right now MAZE is at about 1.1x its normal volume and REPL is at about 0.8x, so MAZE is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading MAZE or REPL? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore MAZE and REPL comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.